NCT04172168

Brief Summary

The Left Ventricular Free-wall Ruptrue (LVFR) is a serious complication caused high mortality.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
17,568

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
8.9 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 21, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

9 years

First QC Date

November 18, 2019

Last Update Submit

March 31, 2021

Conditions

Acute Myocardial Infarction

Keywords

Left Ventricular Free-wall RuptrueAcute myocardial infarctionCoronary angiography

Outcome Measures

Primary Outcomes (1)

  • Rate of heart ruputre

    Left Ventricular Free-wall Ruptrue

    Mortality 30 days

Secondary Outcomes (2)

  • Rate of cardiogenic shock

    Hospitalization 30 days

  • Rate of cardiac arrest

    Hospitalization 30 days

Study Arms (2)

Heart rupture

Include left ventricular free-wall ruptrue after AMI

Diagnostic Test: Heart rupture

Non heart rupture

AMI with non heart rupture

Interventions

Heart ruptureDIAGNOSTIC_TEST

Left ventricular free-wall ruptrue after AMI

Heart rupture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population of acute myocardial infarction (STEMI or NSTEMI) patients.

You may qualify if:

  • Patients be admitted for acute myocardial infarction (STEMI or NSTEMI)

You may not qualify if:

  • Non-cardiovascular comorbidity for AMI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xiamen Cardiovascular Hospital Xiamen University

Xiamen, Fujian, 361000, China

RECRUITING

Study Officials

  • Yan Wang, PhD

    Cardiovascular Hospital, Xiamen University

    STUDY CHAIR

Central Study Contacts

Yan Wang, PhD

CONTACT

+8613860488088wy@medmail.com.cn

Bin Wang, PhD

CONTACT

+8613400664305mocw361@163.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
President

Study Record Dates

First Submitted

November 18, 2019

First Posted

November 21, 2019

Study Start

January 1, 2011

Primary Completion

December 31, 2019

Study Completion

March 31, 2021

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)